Atara Biotherapeutics Inc. buy melinda
Start price
17.03.20
/
50%
€5.79
Target price
04.11.21
€15.00
Performance (%)
200.79%
End price
05.11.21
€17.41
Summary
This prediction ended on 05.11.21 with a price of €17.41. With a performance of 200.79% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Atara Biotherapeutics Inc. | -17.966% | -17.966% | -68.034% | -95.312% |
iShares Core DAX® | -0.683% | 1.890% | 15.367% | 17.155% |
iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% | 56.187% |
iShares Nikkei 225® | -1.486% | -2.361% | 7.668% | 3.633% |
iShares S&P 500 | -0.523% | 2.324% | 25.460% | 46.452% |
According to melinda what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Atara Biotherapeutics Inc. diskutieren
Buy mit Kursziel 10,0
Kursziel geändert auf 20,0
Kursziel geändert auf 15,0
In the thread Trading Atara Biotherapeutics Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.27
12.03.20
12.03.20
€12.00
17.03.20
17.03.20
-20.36%
17.03.20
17.03.20
Could be worthwhile Investment >10% per year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€36.68
03.04.19
03.04.19
€40.59
30.10.19
30.10.19
-73.34%
30.10.19
30.10.19
Could be worthwhile Investment >10% per year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€25.35
13.01.18
13.01.18
€28.41
22.01.18
22.01.18
15.84%
22.01.18
22.01.18
Could be worthwhile Investment >10% per year